SYNOPET HA

The Triple-Action Formula for Joint Resilience.
Next-Generation Mobility Support.
Joint Care
Dog & Cat
Tablet

Composition

Glucosamine HCl: 450 mg
Chondroitin Sulphate: 330 mg
Hyaluronic Acid: 18 mg
Dimethylglycine: 100 mg
Methylsulfonylmethane: 200 mg
EPA and DHA: 50 mg, Curcumin: 6.3 mg
Bromelain: 18 mg
Manganese Glycinate: 40 mg
Ascorbic acid (Coated): 30 mg
Vitamin E: 10 IU
Boswellia serrata: 50 mg

Indications

Treatment and management of mild to severe osteoarthritis (OA).
Support for recovery after orthopedic joint surgery or joint trauma.
Improving joint flexibility and mobility in geriatric or working animals.
Management of hip and elbow dysplasia symptoms.
Prophylactic use in large or giant breed dogs prone to joint disease.

Mechanism of Action

SYNOPET HA employs multi-target action to combat Osteoarthritis (OA). Glucosamine/Chondroitin rebuild the cartilage matrix. Hyaluronic Acid improves the viscosity and lubrication of synovial fluid. MSM and cofactors support collagen structure. Crucially, the blend of EPA/DHA, Curcumin, and Boswellia serrata delivers potent anti-inflammatory effects by inhibiting leukotriene and prostaglandin synthesis. This synergistic approach reduces pain, preserves joint integrity, and restores functional mobility.

Benefits

Curcumin: 6.3 mg
Bromelain: 18 mg
Manganese Glycinate: 40 mg
Ascorbic acid (Coated): 30 mg
Vitamin E: 10 IU
Boswellia serrata: 50 mg

Usage & Recommendation

Dogs:
Dosage should be tailored to the animal's weight, usually given once daily.
15-20 Kg body weight ; 1 tablet per day
20-40 Kg body weight : 2 tablets per day
Over 40 Kg body weight : 3 tablets per day
Method: Administer orally, ideally with food.
Duration: Typically used long-term for chronic joint conditions.

Presentation

Strip of 15 tablets

Dosage

Tablet

Category:
×

Asia

×

America

×

Middle East

×

Africa

×

Anz

×

south America

×

EU

×

India

×